HUVEC/TERT22024-01-02T09:39:44+00:00

Umbilical cord – vascular system

HUVEC/TERT2

Evercyte ́s human umbilical vein endothelial cell line HUVEC/TERT2 can be grown without limitations while maintaining expression of cell type specific markers and function. Therefore, these cells are useful for setting up in vitro bioassays for studying angiogenesis in e.g. wound healing or metastasis as well as bioassays for testing the angiogenic properties of novel drugs. Additionally, the cell line is the perfect starting material for genetic engineering to create important disease models.

Print Friendly, PDF & Email

from

€ 1600,–

HUVEC/TERT2
Cat#: CHT-006-0008

ONLY FOR NON PROFIT

FOR PROFIT INDUSTRY

FOR PROFIT-CRO

Related Products

human umbilical vein endothelial cells grown under xeno-free conditions

HUVEC/TERT66

Related Services

Customer Reviews

“I have had the pleasure of working with Evercyte for the last few years. We continually rely on Evercyte because of the high-quality data that they produce, their diligent responsiveness, and their excellent customer service.”

 

Josh Garlich, Senior Research Scientist, Apellis Pharmaceuticals, Inc.

“Cytonus has been working with Evercyte from many years as they are a trusted partner and have always delivered the highest quality cell lines to advance our platform.  We routinely draw on their expertise to meet cellular engineering challenges and they have not disappointed.”

Remo Moomiaie-Qajar, Cytonus Therapeutics, Inc.

all about
our cells

Extracellular vesicles and angiogenesis

bioassays to test the neo-angiogenic potential of extracellular vesicles

3D in vitro angiogenesis assays

HUVEC/TERT2 cells qualify for testing pro- or anti-angiogenic compounds

toxicity studies

HUVEC/TERT2 cells are useful to evaluate toxicity of aroma compounds in e-cigarette products

Related Products

human microvascular endothelial cell line HDMVEC/TERT164

Related Services

testing pro- and anti-angiogenic properties of novel compounds using 2D and 3D cell culture systems

morphology and differentiation potential of human dermal microvascular endothelial cell line HDMVEC/TERT164

Customer Reviews

“I have had the pleasure of working with Evercyte for the last few years. We continually rely on Evercyte because of the high-quality data that they produce, their diligent responsiveness, and their excellent customer service.”

 

Josh Garlich, Senior Research Scientist, Apellis Pharmaceuticals, Inc.

“Cytonus has been working with Evercyte from many years as they are a trusted partner and have always delivered the highest quality cell lines to advance our platform.  We routinely draw on their expertise to meet cellular engineering challenges and they have not disappointed.”

Remo Moomiaie-Qajar, Cytonus Therapeutics, Inc.

Print Friendly, PDF & Email

from

€ 1300,–

HUVEC/TERT2
Cat#: CHT-006-0008

ONLY FOR NON PROFIT

FOR PROFIT INDUSTRY

FOR PROFIT-CRO

Title

Go to Top